Who has invested in Vial?

General Catalyst are named among the investors backing Vial.

Vial Funding: $100M Raised, Series B (2022)

Vial funding overview

Vial is based in San Francisco. Vial has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for Vial runs through 2022; nothing later has been disclosed. Investors on record include General Catalyst.

Vial at a glance

Total raised: $100M
Latest round: Series B
Latest round date: January 2022
Headquarters: San Francisco
Notable investors: General Catalyst

Frequently asked about Vial funding

How much has Vial raised?: Vial has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Vial?: General Catalyst are named among the investors backing Vial.
What was the latest Vial funding round?: The most recent disclosed round is a Series B, announced in January 2022.
Where is Vial based?: Vial is based in San Francisco.
When did Vial last raise?: The last disclosed Vial round closed in January 2022 at Series B.

Totals shown for Vial aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.

Vial Funding: $100M Raised, Series B (2022)

Vial funding overview

Vial at a glance

Frequently asked about Vial funding

Companies related to Vial (36)

Browse related funding lists (6)